← All stocks

Tyra Biosciences, Inc.

TYRA Net buying
CIK 0001863127 #2234 in the set updated 17 Sep 2026
Bought (120 mo)
$76.97M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$31.98M
$18.29M on a plan · $5.14M straight out of an exercise
Sold at will
$8.54M
33 of 134 sales
Net
+$44.99M
+$68.43M against sales at will

By person

23 insiders · 150 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
RA CAPITAL MANAGEMENT, L.P. entity
Director
$55.16M (8)
+$55.16M
10,259,291
17.19%
$211.12M
Boxer Capital, LLC entity
See Remarks
$11.64M (2)
+$11.64M
6,534,298
10.95%
$134.47M
Bensen Daniel
Chief Discovery Officer
$9.54M (55) scheduled
−$9.54M
146,981
0.2463%
$3.02M
−71.7%
Harris Todd
President and CEO
$8.12M (43) scheduled
−$8.12M
1,437,631
2.41%
$29.58M
−13.5%
Cormorant Asset Management, LP entity
Former 10% Owner
$5.00M (1)
+$5.00M
1,069,932
1.79%
$22.02M
Kjellson Nina S
Director
$4.41M (26)
−$4.41M
443,885
0.7438%
$9.13M
MVA Investors, LLC entity
10% owner
$3.50M (2)
−$3.50M
22,527
0.0377%
$463.57K
−92.2%
MORE ROBERT J
Director
$2.50M (1)
$5.25M (2) scheduled
−$2.75M
3,823,425
6.41%
$78.68M
+3,286%
Alta Partners NextGen Fund II Management, LLC entity
10% owner
$2.50M (1)
+$2.50M
4,080,296
6.84%
$83.97M
+3,513%
KAPLAN GILLA
Director
$1.16M (6)
−$1.16M
28,231
0.0473%
$580.95K
−79.0%
Fuhrman Alan
Chief Financial Officer
$151.95K (1)
+$151.95K
36,164
0.0606%
$744.20K
Verjee Rehan
Director
$20.00K (1)
+$20.00K
972
0.0016%
$20.00K
Boxer Capital Management, LLC entity
See remarks
4,448,359
7.45%
$91.54M
−31.0%
Canaan XI L.P.
10% owner
473,396
0.7933%
$9.74M
Hudkins Robert L.
Chief Technology Officer
273,576
0.4584%
$5.63M
+1.3%
Swanson Ronald V.
Chief Scientific Officer
273,254
0.4579%
$5.62M
+1.2%
CHEN ISAN
Director
192,783
0.3230%
$3.97M
+46.8%
van den Boom Esther
Chief Financial Officer
143,151
0.2399%
$2.95M
+20.7%
Tada Hiroomi
Chief Medical Officer
86,435
0.1448%
$1.78M
+10.9%
Patel Piyush R.
Chief Development Officer
73,794
0.1237%
$1.52M
−45.4%
Rueb Yuliya
Vice President, Finance (PAO)
43,354
0.0726%
$892.16K
+23.8%
Warner Douglas J
Chief Medical Officer
25,000
0.0419%
$514.46K
Ashar Bhavesh
Chief Operating Officer
15,013
0.0252%
$308.94K
Insider
Date
Role
Action
Shares
Price
Amount
KAPLAN GILLA
25 Mar 2026
Director
Sold after exercise
14,295
$36.97
$528.51K
Bensen Daniel
2 Feb 2024
Chief Operating Officer
Sold after exercise
2,300
$17.04
$39.20K
Bensen Daniel
2 Feb 2024
Chief Operating Officer
Sold after exercise
73,093
$16.31
$1.19M
Bensen Daniel
21 Jul 2023
Chief Operating Officer
Sold after exercise
3,900
$16.01
$62.43K
Bensen Daniel
19 Jul 2023
Chief Operating Officer
Sold after exercise
207
$16.08
$3.33K
Bensen Daniel
17 Jul 2023
Chief Operating Officer
Sold after exercise
1,900
$16.03
$30.46K
Bensen Daniel
13 Jul 2023
Chief Operating Officer
Sold after exercise
500
$16.13
$8.07K
Bensen Daniel
12 Jul 2023
Chief Operating Officer
Sold after exercise
201
$16.23
$3.26K
Bensen Daniel
11 Jul 2023
Chief Operating Officer
Sold after exercise
500
$16.02
$8.01K
Bensen Daniel
10 Jul 2023
Chief Operating Officer
Sold after exercise
1,202
$16.01
$19.24K
Bensen Daniel
3 Jul 2023
Chief Operating Officer
Sold after exercise
400
$17.04
$6.81K
Bensen Daniel
3 Jul 2023
Chief Operating Officer
Sold after exercise
3,865
$16.30
$63.00K
Bensen Daniel
30 Jun 2023
Chief Operating Officer
Sold after exercise
18,819
$16.97
$319.42K
Bensen Daniel
29 Jun 2023
Chief Operating Officer
Sold after exercise
17,281
$16.49
$285.01K
Bensen Daniel
28 Jun 2023
Chief Operating Officer
Sold after exercise
13,524
$16.91
$228.64K
Bensen Daniel
27 Jun 2023
Chief Operating Officer
Sold after exercise
8,135
$17.09
$139.02K
Bensen Daniel
27 Jun 2023
Chief Operating Officer
Sold after exercise
7,893
$16.73
$132.05K
Bensen Daniel
26 Jun 2023
Chief Operating Officer
Sold after exercise
6,370
$17.24
$109.79K
Bensen Daniel
26 Jun 2023
Chief Operating Officer
Sold after exercise
10,862
$16.49
$179.13K
Bensen Daniel
15 Jun 2023
Chief Operating Officer
Sold after exercise
12,592
$16.15
$203.30K
Harris Todd
15 Jun 2023
Chief Executive Officer
Sold after exercise
12,773
$16.13
$206.00K
Bensen Daniel
14 Jun 2023
Chief Operating Officer
Sold after exercise
120
$16.45
$1.97K
Bensen Daniel
13 Jun 2023
Chief Operating Officer
Sold after exercise
5,628
$16.01
$90.13K
Harris Todd
13 Jun 2023
Chief Executive Officer
Sold after exercise
7,927
$16.00
$126.87K
Bensen Daniel
3 Apr 2023
Chief Operating Officer
Sold after exercise
2,000
$16.16
$32.31K
Harris Todd
3 Apr 2023
Chief Executive Officer
Sold after exercise
2,000
$16.13
$32.25K
Harris Todd
31 Mar 2023
Chief Executive Officer
Sold after exercise
500
$16.05
$8.02K
Bensen Daniel
31 Mar 2023
Chief Operating Officer
Sold after exercise
400
$16.00
$6.40K
Harris Todd
30 Mar 2023
Chief Executive Officer
Sold after exercise
2,407
$16.02
$38.55K
Bensen Daniel
30 Mar 2023
Chief Operating Officer
Sold after exercise
2,000
$16.01
$32.02K
Bensen Daniel
29 Mar 2023
Chief Operating Officer
Sold after exercise
2,187
$16.21
$35.46K
Harris Todd
29 Mar 2023
Chief Executive Officer
Sold after exercise
1,420
$16.18
$22.98K
Harris Todd
28 Mar 2023
Chief Executive Officer
Sold after exercise
2,779
$16.00
$44.46K
Bensen Daniel
28 Mar 2023
Chief Operating Officer
Sold after exercise
3,346
$16.00
$53.54K
Harris Todd
27 Mar 2023
Chief Executive Officer
Sold after exercise
2,963
$16.00
$47.41K
Bensen Daniel
27 Mar 2023
Chief Operating Officer
Sold after exercise
8,048
$16.00
$128.77K
Harris Todd
24 Mar 2023
Chief Executive Officer
Sold after exercise
170
$16.00
$2.72K
Bensen Daniel
23 Mar 2023
Chief Operating Officer
Sold after exercise
4,827
$16.00
$77.23K
Harris Todd
23 Mar 2023
Chief Executive Officer
Sold after exercise
2,800
$16.00
$44.80K
Bensen Daniel
22 Mar 2023
Chief Operating Officer
Sold after exercise
3,800
$16.00
$60.80K
Harris Todd
22 Mar 2023
Chief Executive Officer
Sold after exercise
4,043
$16.00
$64.69K
Bensen Daniel
21 Mar 2023
Chief Operating Officer
Sold after exercise
14,100
$16.00
$225.60K
Harris Todd
21 Mar 2023
Chief Executive Officer
Sold after exercise
12,393
$16.00
$198.29K

What was left out

Form 4 filings counted 167
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 19
Sales on a Rule 10b5-1 plan 58
Sales straight out of an exercise 43
Sales at will 33
Transactions with no price 0
Shares from compensation/vesting 36,208,337
Sales filed before the plan box existed 2
History held since 17 Sep 2021